ALFA Finder| Revenue growth | Standalone Q2 +24.5% YoY; consolidated Q2 -9.2% YoY |
|---|---|
| Margins | Standalone Q2 EBITDA margin 9.5%; consolidated 20.1% |
| Order book | ₹83.4 Cr; Rail ₹24.9 Cr, Non-Rail ₹58.5 Cr; Q2 booking ₹16 Cr |
| Demand visibility | Unexecuted order book ₹83.4 Cr at 30 Sep 2026 |
Growth
Standalone H1 total income ₹3,296L (+22.5%); Q2 EBITDA ₹157L at 9.5% margin. Consolidated Q2 income ₹1,187L (-9.2% YoY).
Outlook
No explicit FY27 growth guidance. ₹70 Cr identified for next 12 months, not guaranteed. 2030 ambition of 15+ Bn litres recycling.
Risks
Consolidated revenue declined YoY. Net debt/equity rose to 0.82x from 0.74x. Megaliter capex funded by borrowings and outside equity.
Investor Presentation filed with NSE, NSE: BANKA. Summary written with AI assistance from the document.
Banka Bioloo Ltd: key numbers
- Share price
- ₹78.00
- Market cap
- ₹85.31 Cr
- Revenue (annual)
- ₹57.09 Cr
- Net profit (annual)
- ₹0.35 Cr
- P/E (TTM)
- 55.0×Sector 21.5×
- Promoter holding
- 52.02%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Banka Bioloo Ltd
All →Banka Bioloo Employee Stock Options
Banka BioLoo received NSE listing and trading approval for 5,000 equity shares allotted under its ESOP scheme. Dealings in the shares begin on November 16, 2026.
Banka Bioloo Q2 FY27 Results: Turns Profitable, Net Profit ₹0.1 Cr
Banka Bioloo Ltd reported revenue from operations of ₹11.8 Cr (-9.2% YoY) and net profit of ₹0.1 Cr for Q2 FY27.
- Key figure
- Net profit ₹0.1 Cr
Banka Bioloo Price Movement Clarification
Banka BioLoo responded to NSE's query on a significant price movement, stating the spurt was market-driven. The company says it has made all required disclosures and has no pending price-sensitive announcement.
Banka Bioloo Employee Stock Options
Banka BioLoo Limited has granted 2,000 stock options under its Employees Stock Option Plan 2023. The options are exercisable at face value of Rs.10 per share.
Banka Bioloo Investor Presentation: Key Takeaways
Banka Bio reported FY26 total income of ₹58.4 cr (+7.1% YoY) and a return to profitability with ₹0.39 cr PAT. Strategy focuses on converting Megaliter's asset-light contracted revenues into recurring cash flows.
Banka Bioloo Annual General Meeting
Banka BioLoo Limited conducted its 14th Annual General Meeting on September 17, 2026. The meeting covered routine business, including financial statement adoption and director re-appointment.